Saturday 17 October 2026
Export CRDL’s income statement to Excel — free account
Cardiol Therapeutics Inc.
CRDL Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, EPS grew 42.9%, free cash flow grew 10.6% and total debt fell 38.8%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
1.10
0.05
−4.35%
Follow CRDL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
5.01 | 3.93 | 3.83 | 3.59 | |
Current Ratio |
5.55 | 4.39 | 4.16 | 3.89 | |
Net Debt/EBITDA |
3.28 | 2.85 | 4.81 | 1.14 | |
Debt/Assets |
0.22% | 0.24% | 0.37% | 0.75% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.01 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.71 | 0.69 | 1.34 | 0.70 | |
Capex/Depreciation |
(0.23) | (1.78) | (0.11) | (0.12) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.03) | (0.05) | (0.04) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.05) | (0.04) | (0.06) | |
Cash per Share |
0.16 | 0.19 | 0.18 | 0.10 | |
Shareholders Equity per Share |
0.15 | 0.16 | 0.15 | 0.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.15 | 0.16 | 0.15 | 0.08 | |
Free Cash Flow |
(3.12) | (5.51) | (3.55) | (5.06) | |
Working Capital |
17.31 | 17.60 | 12.77 | 6.91 | |
Capital Expenditures |
0.00 | (0.03) | 0.00 | 0.00 | |
Net Current Asset Value |
17.26 | 17.54 | 12.71 | 6.84 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.21 | 0.24 | 0.21 | 0.17 | |
Average Payables |
4.24 | 3.93 | 3.79 | 3.72 | |
Average Assets |
17.81 | 20.31 | 20.08 | 11.12 | |
Average Common Equity |
12.95 | 14.95 | 15.42 | 7.29 |
Columns are period end dates